Brown Shoe Company (BWS – Snapshot Report) is cashing in on demand for new shoes as it handily beat the Zacks Consensus in the third quarter. This Zacks Rank #1 (Strong Buy) also raised full year guidance. Brown Shoe Company is a global footwear company that owns numerous well-known brands including Dr. Scholl’s, LifeStride, Sam Edelman, Franco Sarto,…
A few weeks ago, I was fortunate enough to visit an old friend at Google, NY. Now why is that interesting? Because I call Tomer “An old friend” despite the fact that I had never met him. “Wow, you have a strange definition of friend” is probably what you’re thinking. Could very well be, but…
(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are sometimes posted on…
The race to declare dominance over a particular segment of the market is one that fund companies dream about. They work hard to conjugate unique strategies that stand above plain vanilla indexes in the hopes that their secret sauce adds a measure of value. While this year found many fundamental or “smart beta” ETFs at parity with…
Add these factors up and we conclude there is no visible price limit on oil after supply falters. I’ve been discussing the concept of an Oil Head-Fake since 2008, most recently in The Oil Head-Fake: The Illusion that Lower Oil Prices Are Positive (September 29, 2014) Oil: One Last Head-Fake? (May 9, 2008) The basic idea is straightforward: as global demand…
Russia finds itself in a double bind. It is subject to a number of sanctions from the European Union, USA and other trading partners over what they perceive to be undue involvement in the affairs of another sovereign state, Ukraine. For its part, Russia denies that it is involved in assisting Ukrainian rebels who wish to break…
CytRx Corporation (NASDAQ: CYTR), announced that the Company has received written notice from the United States Food and Drug Administration (FDA) that its clinical trials for aldoxorubicin have been placed on partial clinical hold. The news supplements and is consistent with the prior verbal communications from the FDA. As previously announced, all currently enrolled patients…
Wage Inflation “Remained Subdued” Why does the stock market care about wages? If our paychecks get bigger, we have more money to spend. If we have more money to spend, that adds to demand pressure in the supply-and-demand balance. Increasing demand for goods and services can lead to higher prices for those good and services….
The Upside of Error and Misfortune We are here in Lower Manhattan. It does not seem much like an “urban jungle.” It is too cold and rainy. After a brief excursion outside, you have to warm yourself by an artificial fire, with a coffee. Or, after 7 p.m., with a glass of Jameson. Then the…
Biogen Idec (BIIB) reported on December 2, 2014 that it had achieved positive results in an early study in patients with Alzheimer’s. Alzheimer’s is a brain deterioration in mental status that progressively gets worse over time. Alzheimer’s affects memory, behavior, and thinking which can severely impact a patient’s life. Biogen Idec had started a study…
